Precision Biosciences, Inc.
Clinical trials sponsored by Precision Biosciences, Inc., explained in plain language.
-
One-Shot gene therapy trial offers hope for boys with devastating muscle disease
Disease control Not yet recruitingThis early-stage trial is testing a new, one-time gene therapy called PBGENE-DMD for boys with Duchenne muscular dystrophy (DMD). The study aims to see if the treatment is safe and if it can correct the underlying genetic cause of the disease by helping muscles produce a needed p…
Phase: PHASE1, PHASE2 • Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists track Long-Term safety of pioneering hepatitis b gene therapy
Disease control Not yet recruitingThis study aims to monitor the long-term safety of an experimental gene-editing treatment called PBGENE-HBV in people with chronic hepatitis B. It will follow 45 participants who received the treatment in a previous trial, checking for any delayed side effects. No new treatment i…
Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC